Market Statistics Key Takeaways North America led with a 75.46% revenue share in 2025
In controlled trials, RDN-delivered MNT modestly but meaningfully improves dietary quality, body weight, waist circumference, glycemic control, blood pressure, and blood cholesterol levels [[207], [208], [209], [210]]
In short: The medication and clinical experience are solid, and the variety of formats is a genuine differentiator
The status quo has not served them
This can also be seen after gall bladder removal surgery and I wonder if patients with diarrhea on retatrutide wouldnt benefit from psyllium husk fiber(aka Metamucil in the USA) or taking low doses of drugs called bile acid sequestrants until their GI can adjust to the retatrutide